Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Receivables (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Change in Receivables for 16 consecutive years, with $244000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables rose 112.43% year-over-year to $244000.0, compared with a TTM value of -$549000.0 through Sep 2025, down 13.43%, and an annual FY2024 reading of -$2.6 million, down 156.23% over the prior year.
  • Change in Receivables was $244000.0 for Q3 2025 at Rockwell Medical, up from -$1.6 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $4.0 million in Q3 2023 and bottomed at -$2.0 million in Q3 2024.
  • Average Change in Receivables over 5 years is $218789.5, with a median of -$123000.0 recorded in 2021.
  • The sharpest move saw Change in Receivables tumbled 800.81% in 2022, then surged 646.33% in 2023.
  • Year by year, Change in Receivables stood at -$123000.0 in 2021, then crashed by 800.81% to -$1.1 million in 2022, then surged by 238.99% to $1.5 million in 2023, then crashed by 138.05% to -$586000.0 in 2024, then surged by 141.64% to $244000.0 in 2025.
  • Business Quant data shows Change in Receivables for RMTI at $244000.0 in Q3 2025, -$1.6 million in Q2 2025, and $1.4 million in Q1 2025.